Critical Review: Editas Medicine (EDIT) and CytRx Corporation (CYTR) – Dispatch Tribunal
|
Critical Review: Editas Medicine (EDIT) and CytRx Corporation (CYTR)
Dispatch Tribunal CRISPR uses a protein-ribonucleic acid (RNA) complex composed of an enzyme, including either CRISPR associated protein 9 (Cas9) or CRISPR from Prevotella and Francisella 1 (Cpf1), bound to a guide RNA molecule designed to recognize a particular … |
